Early locomotor training with clonidine in spinal cats

Journal of Neurophysiology
C ChauS Rossignol

Abstract

Clonidine, a noradrenergic alpha-2 agonist, can initiate locomotion early after spinalization in cats. Because this effect lasts 4-6 h, we have injected clonidine daily, intraperitoneally or intrathecally, and intensively trained five spinal cats to perform hindlimb walking on a treadmill starting at day 3 and continuing until 10 days posttransection. Each day, clonidine was injected to induce locomotor activity and cats were trained to walk with as much weight support as possible and at different speeds during multiple (1-5) locomotor training sessions, each lasting from 10 to 20 min, until the effects of clonidine wore off. Electromyographic (EMG) activity synchronized to video images of the hindlimbs were recorded before and after each clonidine injection. The results showed, first, a day-to-day change of the locomotor pattern induced by clonidine from the 3rd to the 11th day including an increase in the duration of the step cycle, an increase in the duration of extensor EMG activity, and an increase in total angular excursion of the hip, knee, and ankle joints. Second, after 6-11 days of this regimen, there was an emergence of a coordinated locomotor pattern with weight support of the hindquarters that was visible even befo...Continue Reading

References

May 1, 1977·Clinical Pharmacology and Therapeutics·D S DaviesC T Dollery
Dec 1, 1991·Journal of Neurophysiology·K G Pearson, S Rossignol
Apr 30, 1990·Brain Research·R G LovelyV R Edgerton
Mar 1, 1989·Journal of Neurophysiology·J R Wolpaw, C L Lee
Aug 1, 1989·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·M Visintin, H Barbeau
May 26, 1987·Brain Research·H Barbeau, S Rossignol
Nov 1, 1974·The Journal of Comparative Neurology·M E Goldberger, M Murray
Nov 1, 1974·The Journal of Comparative Neurology·M Murray, M E Goldberger
Feb 14, 1973·Brain Research·H Forssberg, S Grillner
Apr 1, 1973·Neuropharmacology·J Häggendal, A Dahlström
Jun 10, 1982·Brain Research·M E Goldberger, M Murray
May 1, 1995·Annals of Neurology·V DietzL Baumgartner
Nov 5, 1994·Lancet·V DietzL Jensen
Jul 1, 1996·Journal of Neurophysiology·M BélangerS Rossignol
Jun 1, 1951·Journal of Comparative and Physiological Psychology·P S SHURRAGER, R A DYKMAN

❮ Previous
Next ❯

Citations

Jun 9, 2000·Annual Review of Physiology·K G Pearson
Mar 17, 2001·Nature Reviews. Neuroscience·E BizziA d'Avella
Aug 25, 2001·Annual Review of Neuroscience·J R Wolpaw, A M Tennissen
Jan 10, 2006·Journal of Neurologic Physical Therapy : JNPT·Laurent J Bouyer
Jun 14, 2008·Journal of Neurophysiology·Hugo Delivet-MongrainSerge Rossignol
Mar 28, 2009·Journal of Neuroscience Research·Pierre A Guertin, Inge Steuer
Apr 8, 2011·Annual Review of Neuroscience·Serge Rossignol, Alain Frigon
Jul 23, 2013·Journal of Neurologic Physical Therapy : JNPT·Denise M PetersStacy L Fritz
Mar 21, 2003·Neurorehabilitation and Neural Repair·Hugues Barbeau
Dec 6, 2002·Journal of Neurophysiology·Connie ChauSerge Rossignol
Jan 14, 2005·Journal of Neurophysiology·C LangletS Rossignol
Jun 26, 2004·Annual Review of Neuroscience·V Reggie EdgertonRoland R Roy
Apr 11, 2007·Journal of Neurologic Physical Therapy : JNPT·Catherine E LangChristopher Gnip
Aug 31, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Serge Rossignol
Dec 7, 2011·Journal of Neurotrauma·Antoinette DomingoUNKNOWN Spinal Cord Injury Rehabilitation Evidence Research Team
Mar 28, 2013·Annals of the New York Academy of Sciences·Marina Martinez, Serge Rossignol
Apr 13, 2018·Journal of Neurotrauma·Renaud Jeffrey-GauthierHugues Leblond
Dec 31, 1998·Current Opinion in Neurology·M Giménez y Ribotta, A Privat
Feb 3, 1999·Annals of the New York Academy of Sciences·H BarbeauM Ladouceur
Feb 28, 2001·Journal of Child Neurology·F J ThompsonP Bose
May 3, 2005·Journal of Comparative Physiology. A, Neuroethology, Sensory, Neural, and Behavioral Physiology·Angela L Ridgel, Roy E Ritzmann
Apr 25, 2006·Journal of Neurotrauma·V Reggie EdgertonRoland R Roy
Feb 6, 2020·Frontiers in Cellular Neuroscience·Yann Develle, Hugues Leblond
Jul 20, 2002·Spine·Brian K KwonWolfram Tetzlaff
Jan 11, 2002·Physical Therapy·Marilyn MacKay-Lyons
Jun 15, 2011·Journal of Neurotrauma·Shyam Aravamudhan, Ravi V Bellamkonda
Sep 22, 2009·Nature Neuroscience·Grégoire CourtineV Reggie Edgerton
Dec 19, 2009·Neurorehabilitation and Neural Repair·Sylvie NadeauSerge Rossignol
Feb 3, 1999·Annals of the New York Academy of Sciences·S RossignolT A Reader
Mar 24, 2004·Spinal Cord·J F DitunnoA S Burns

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.